Ascelia Pharma AB
STO:ACE

Watchlist Manager
Ascelia Pharma AB Logo
Ascelia Pharma AB
STO:ACE
Watchlist
Price: 4.75 SEK 3.71% Market Closed
Market Cap: 551.1m SEK

Wall Street
Price Targets

ACE Price Targets Summary
Ascelia Pharma AB

Wall Street analysts forecast ACE stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ACE is 11.22 SEK with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.

Lowest
Price Target
11.11 SEK
134% Upside
Average
Price Target
11.22 SEK
136% Upside
Highest
Price Target
11.55 SEK
143% Upside
Ascelia Pharma AB Competitors:
Price Targets
VRTX
Vertex Pharmaceuticals Inc
24% Upside
ALKS
Alkermes Plc
43% Upside
SKYE
Skye Bioscience Inc
331% Upside
086890
Isu Abxis Co Ltd
90% Upside
RCKT
Rocket Pharmaceuticals Inc
113% Upside
BBIO
BridgeBio Pharma Inc
29% Upside
NIOX
Niox Group PLC
15% Upside
ARGX
argenx SE
25% Upside

Revenue
Forecast

Revenue Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
17%
Average Beat

Net Income
Forecast

Net Income Estimate
Ascelia Pharma AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-55%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ACE's stock price target?
Price Target
11.22 SEK

According to Wall Street analysts, the average 1-year price target for ACE is 11.22 SEK with a low forecast of 11.11 SEK and a high forecast of 11.55 SEK.

Back to Top